TrialPanorama/TrialPanorama-database huggingface dataset:
Study 7509380 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 17162433 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17162433 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17162433 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 10426453 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 2194509 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 2194509 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22101760 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 10999807 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 18356697 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18356697 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31905885 — Surrogate Endpoint (SUR): Blood pressure
Study 26575248 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23972865 — Surrogate Endpoint (SUR): Blood pressure
Study 2525337 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2525337 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15472200 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25874530 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 25874530 — Safety Biomarker (SAF): BDNF
Study 29935544 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12227400 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 10525709 — Surrogate Endpoint (SUR): Bone mineral density
Study 10525709 — Surrogate Endpoint (SUR): Serum calcium
Study 10525709 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 27695980 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 20298784 — Surrogate Endpoint (SUR): Bone mineral density
Study 20298784 — Surrogate Endpoint (SUR): Serum calcium
Study 18796622 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 18796622 — Surrogate Endpoint (SUR): Blood pressure
Study 18796622 — Surrogate Endpoint (SUR): Serum creatinine
Study 2523645 — Surrogate Endpoint (SUR): Blood pressure
Study 356497 — Surrogate Endpoint (SUR): Blood pressure
Study 356497 — Surrogate Endpoint (SUR): Serum potassium
Study 356497 — Surrogate Endpoint (SUR): Serum sodium
Study 356497 — Surrogate Endpoint (SUR): Serum creatinine
Study 356497 — Surrogate Endpoint (SUR): Serum uric acid
Study 31848551 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21209030 — Surrogate Endpoint (SUR): Bone mineral density
Study 24781851 — Surrogate Endpoint (SUR): Blood pressure
Study 24781851 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1877516 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1877516 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 1877516 — Surrogate Endpoint (SUR): Blood pressure
Study 6401357 — Surrogate Endpoint (SUR): Blood pressure
Study 29698019 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 9488498 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 30274344 — Surrogate Endpoint (SUR): Blood pressure
Study 30274344 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30274344 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12751804 — Predictive Biomarker (PRD): SLC10A3 mRNA
Genes: SLC10A3; DXS253E; P3
Study 30796508 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 30796508 — Surrogate Endpoint (SUR): Blood pressure
Study 29406428 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26523653 — Predictive Biomarker (PRD): NR3C2 mRNA
Genes: NR3C2; MCR; MLR
Study 23733256 — Surrogate Endpoint (SUR): Serum triglycerides
Study 20142024 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 20142024 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15659491 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 15659491 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 103378 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 31577104 — Surrogate Endpoint (SUR): Sperm parameters
Study 21221990 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 15741212 — Surrogate Endpoint (SUR): Serum creatinine
Study 28705885 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 31808659 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study 31808659 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28202370 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 21970138 — Surrogate Endpoint (SUR): Blood pressure
Study 15063762 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study 15063762 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study 15063762 — Predictive Biomarker (PRD): IL10RA mRNA
Genes: IL10RA; IL10R
Study 15063762 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 15063762 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 15063762 — Predictive Biomarker (PRD): NFKB1 mRNA
Genes: NFKB1
Study 15063762 — Predictive Biomarker (PRD): GRAP2 mRNA
Genes: GRAP2; GADS; GRB2L; GRID
Study 15063762 — Predictive Biomarker (PRD): CABIN1 mRNA
Genes: CABIN1; KIAA0330
Study 15063762 — Predictive Biomarker (PRD): IFI27 mRNA
Genes: IFI27
Study 15063762 — Predictive Biomarker (PRD): TNFRSF1A mRNA
Genes: TNFRSF1A; TNFAR; TNFR1
Study 15063762 — Predictive Biomarker (PRD): ALDOB mRNA
Genes: ALDOB; ALDB
Study 9815721 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9815721 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 9815721 — Surrogate Endpoint (SUR): Serum creatinine
Study 11865269 — Surrogate Endpoint (SUR): Blood pressure
Study 3622543 — Surrogate Endpoint (SUR): Blood pressure
Study 19325469 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19325469 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 9200375 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study 25904650 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25904650 — Surrogate Endpoint (SUR): Blood pressure
Study 19897276 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 2977272 — Surrogate Endpoint (SUR): Serum testosterone
Study 17909844 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 10471520 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 8566259 — Surrogate Endpoint (SUR): Bone mineral density
Study 7872224 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7872224 — Surrogate Endpoint (SUR): Blood pressure
Study 7872224 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 20535796 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11000341 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 11000341 — Surrogate Endpoint (SUR): Bone mineral density
Study 11000341 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 1377290 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 24911353 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24911353 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20103722 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 14516890 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 14516890 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23296149 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 9827976 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 2506834 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 29443750 — Surrogate Endpoint (SUR): Forced vital capacity
Study 24096366 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 22154766 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 3512121 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 26448147 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26448147 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19298916 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 19298916 — Surrogate Endpoint (SUR): Serum creatinine
Study 3499456 — Surrogate Endpoint (SUR): Blood pressure
Study 30177465 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 15180756 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 21600388 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 30266677 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 16735934 — Surrogate Endpoint (SUR): Bone mineral density
Study 16735934 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9846844 — Surrogate Endpoint (SUR): Blood pressure
Study 27631562 — Surrogate Endpoint (SUR): Bone mineral density
Study 24722494 — Surrogate Endpoint (SUR): Blood pressure
Study 20736456 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study 20736456 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 20736456 — Predictive Biomarker (PRD): BCL6 mRNA
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study 20736456 — Predictive Biomarker (PRD): IRF4 mRNA
Genes: IRF4; MUM1
Study 9845803 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Trefoil factor 3
Genes: TFF3; ITF; TFI
Study 2158869 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 31953483 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study 26077267 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 26077267 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 10690871 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 10179578 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 31499515 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 27707818 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ERCC2
Genes: MAG; EM9; MGC102762; MGC126218; MGC126219
Study 22337905 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 28434387 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 25385024 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 19526753 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19526753 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 16286908 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 1762311 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 1762311 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 1762311 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study 1762311 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 31703023 — Safety Biomarker (SAF): Clusterin
Genes: CLU; APOJ; CLI; KUB1; AAG4
Study 22865498 — Surrogate Endpoint (SUR): Blood pressure
Study 9590144 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 27930609 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26022948 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12470401 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 9867064 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9867064 — Surrogate Endpoint (SUR): Blood pressure
Study 9867064 — Surrogate Endpoint (SUR): Serum creatinine
Study 22799129 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 31735500 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27853882 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 27853882 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 27853882 — Surrogate Endpoint (SUR): Serum creatinine
Study 25885661 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study 17846293 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 30354969 — Surrogate Endpoint (SUR): Blood pressure
Study 24984683 — Surrogate Endpoint (SUR): Bone mineral density
Study 18554989 — Surrogate Endpoint (SUR): Forced vital capacity
Study 16869716 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 16869716 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 12540501 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study 18194120 — Surrogate Endpoint (SUR): Serum creatinine
Study 7549900 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 2181941 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 26228714 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26228714 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 26228714 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 21423253 — Surrogate Endpoint (SUR): Bone mineral density
Study 17672185 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 9031450 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 9031450 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 9031450 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 28537849 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23570589 — Predictive Biomarker (PRD): KDM5D mRNA
Genes: KDM5D; HY; HYA; JARID1D; KIAA0234; SMCY
Study 21605733 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11785282 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11785282 — Surrogate Endpoint (SUR): Serum creatinine
Study 11785282 — Surrogate Endpoint (SUR): Blood pressure
Study 7834934 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 3413270 — Surrogate Endpoint (SUR): Blood pressure
Study 29802953 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 29802953 — Safety Biomarker (SAF): BDNF
Study 11282760 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 9203228 — Surrogate Endpoint (SUR): Blood pressure
Study 23835546 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 18156649 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 22329352 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study 22329352 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 8665991 — Surrogate Endpoint (SUR): Blood pressure
Study 26842957 — Surrogate Endpoint (SUR): Bone mineral density
Study 20306569 — Surrogate Endpoint (SUR): Blood pressure
Study 21762279 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18048463 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18048463 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 18048463 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 18048463 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 2166455 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19093122 — Predictive Biomarker (PRD): CNR1 mRNA
Genes: CNR1; CNR
Study 17599307 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 9508663 — Predictive Biomarker (PRD): GLI2 mRNA
Genes: GLI2; THP
Study 10211753 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 10211753 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 113095 — Predictive Biomarker (PRD): HHEX mRNA
Genes: HHEX; HEX; PRH; PRHX
Study 10682561 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 10682561 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 2526866 — Surrogate Endpoint (SUR): Serum sodium
Study 27389019 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22929989 — Surrogate Endpoint (SUR): Bacterial count
Study 31377052 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 31377052 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17056939 — Predictive Biomarker (PRD): PIR mRNA
Genes: PIR
Study 12609561 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 10636491 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 10636491 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 10636491 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8873431 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 18712409 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23696281 — Surrogate Endpoint (SUR): Blood pressure
Study 19037756 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 11371413 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Nqo1 mRNA
Genes: NQO1; DIA4; NMOR1
Study 11371413 — Predictive Biomarker (PRD): GSTM1 mRNA
Genes: GSTM1; GST1
Study 31838010 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31838010 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 31838010 — Predictive Biomarker (PRD): Hormone receptor
Study 22958160 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 18339475 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 10793867 — Surrogate Endpoint (SUR): Bone mineral density
Study 25253665 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 22503302 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 7906327 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 21955700 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19212427 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 19212427 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31237322 — Surrogate Endpoint (SUR): Blood pressure
Study 25557762 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 23987161 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 23987161 — Surrogate Endpoint (SUR): Blood pressure
Study 22080012 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 22080012 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 16807618 — Surrogate Endpoint (SUR): Blood pressure
Study 3513943 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 22633601 — Surrogate Endpoint (SUR): Blood pressure
Study 20338292 — Surrogate Endpoint (SUR): Serum creatinine
Study 15988102 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 1649863 — Surrogate Endpoint (SUR): Blood pressure
Study 6858934 — Surrogate Endpoint (SUR): Blood pressure
Study 26821625 — Surrogate Endpoint (SUR): Blood pressure
Study 19580356 — Surrogate Endpoint (SUR): Blood pressure
Study 19580356 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17503670 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17503670 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 15613683 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15613683 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15613683 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 2648839 — Surrogate Endpoint (SUR): Blood pressure
Study 2648839 — Surrogate Endpoint (SUR): Serum calcium
Study 21683321 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 21683321 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21683321 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 19390542 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19390542 — Surrogate Endpoint (SUR): Blood pressure
Study 9413769 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 9413769 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9413769 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 6530538 — Surrogate Endpoint (SUR): Blood pressure
Study 30659039 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22828688 — Surrogate Endpoint (SUR): Blood pressure
Study 17105818 — Predictive Biomarker (PRD): GP1BA mRNA
Genes: GP1BA
Study 12486428 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein